Human Recombinant IL-17A (from E. coli)

Lieferant: Shenandoah Biotechnology

100-87-100UG 100-87-1MG 100-87-25UG 100-87-500UG 100-87-5UG
SHBT100-87-100UGEA 453 EUR
SHBT100-87-100UG SHBT100-87-1MG SHBT100-87-25UG SHBT100-87-500UG SHBT100-87-5UG
Human Recombinant IL-17A (from E. coli)
Proteine und Peptide

Interleukin 21 (IL-21) is a member of the common-gamma chain family of cytokines that are involved in immunoregulation. IL-21 is normally expressed by activated CD4+ T cells and is aberrantly expressed in Hodgkin lymphoma cells. The IL-21 receptor (IL-21R) activates the JAK/STAT signaling pathway and is expressed on T, B, and natural killer (NK) cells.


  • High quality
  • Low endotoxin
  • Affordable


Within the B cell lineage, IL-21 is a switch factor regulating IgG1 and IgG3 antibody production. IL-21 also cooperates with IL-4 for the production of multiple antibody classes in B cells. IL-21 has pleiotropic effects on the proliferation, differentiation, and effector functions of B, T, NK, and dendritic cells.


Elevated levels of IL-17A are associated with rheumatoid arthritis, airway inflammation, allograft rejection, inflammatory bowel disease, psoriasis, cancer, and multiple sclerosis. Human, mouse, and rat IL-17A show activity on mouse cells.


Lieferumfang: Certificate of analysis (COA) is supplied with each product shipped detailing purity, formulation, biological activity, endotoxin levels, reconstitution instructions and recommended storage conditions.


Bitte beachten For research use only.

Bestellen


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR